… neural part of the eye, the retina in patients suffering from Parkinson Disease and in healthy, age matched subjects. … Patients diagnosed with Parkinson Disease and not suffering from eye disease will be examined and the back of their eye …

… consisting of CoQ10 and vitamin E (WS-CoQ10), licensed from the National Research Council Canada.  This formulation … in the management of neurodegeneration: lessons from the application of water-soluble Coenzyme Q10 …

… with native alpha-synuclein as a control immunogen. Results from the first assay showed that all three isomers displayed … models in each group but the variability did not result from the measurement itself because every measurement was …

… for cognitive impairments and dementia in PD. Results from this study will have an immediate impact on clinical … Patterns of amyloid deposition distinguish non-demented PD from normal aging. Presented at the Human Amyloid Imaging …

… marker may help to distinguish patients with idiopathic PD from patients with atypical Parkinsonian syndromes. However, … solely through application of TCS whether a person suffers from PD or not. In the second study, patients with clinical …

… whether or not this compound, that prevents alpha-synuclein from taking on toxic conformations in vitro , also prevents … explanation for how clearing misfolded alpha-synuclein from cell membranes may result in improved neuronal …